Phase III Hallmark QUAD: ASV+DCV+Peg+Rib (Nulls/Partials)
Public ClinicalTrials.gov record NCT01573351. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Open-Label Study With Asunaprevir and Daclatasvir Plus Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) (P/R) (QUAD) for Subjects Who Are Null or Partial Responders to Peginterferon Alfa 2a or 2b Plus Ribavirin With Chronic Hepatitis C Genotypes 1 or 4 Infection
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess efficacy, as determined by the proportion of subjects with Sustained Virologic Response at Post-Treatment Week 12 (SVR12), defined as Hepatitis C virus (HCV) Ribonucleic acid (RNA) \< Limit of quantitation (LOQ) at post-treatment Week 12.
Study identification
- NCT ID
- NCT01573351
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 398 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2012 (Type not available)
- Primary completion
- Sep 2013 (Actual)
- Completion
- Dec 2013 (Actual)
- Last update posted
- Oct 9, 2015
2012 – 2013
United States locations
- U.S. sites
- 20
- U.S. states
- 15
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alabama Liver & Digestive Specialists (Alds) | Montgomery | Alabama | 36116 | — |
| Scripps Clinic | La Jolla | California | 92037 | — |
| Scpmg/ Kaiser Permanente Los Angeles Medical Center | Los Angeles | California | 90027 | — |
| University Of Colorado Denver And Hospital | Aurora | Colorado | 80045 | — |
| South Denver Gastroenterology, Pc | Englewood | Colorado | 80113 | — |
| Mayo Clinic | Jacksonville | Florida | 32224 | — |
| University Of Miami Schiff Center For Liver Diseases | Miami | Florida | 33136 | — |
| University Of Chicago Medical Center | Chicago | Illinois | 60637-1432 | — |
| North Shore University Hospital | Manhasset | New York | 11030 | — |
| University Of North Carolina At Chapel Hill School Of Med | Chapel Hill | North Carolina | 27599-7584 | — |
| University Of Cincinnati | Cincinnati | Ohio | 45267 | — |
| Options Health Research, Llc | Tulsa | Oklahoma | 74104 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| University Of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
| Gastro One | Germantown | Tennessee | 38138 | — |
| Baylor College Of Medicine | Houston | Texas | 77030 | — |
| Texas Liver Institute | San Antonio | Texas | 78215 | — |
| Mcguire Dvamc | Richmond | Virginia | 23249 | — |
| Dean Clinic | Madison | Wisconsin | 53715 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 59 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01573351, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 9, 2015 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01573351 live on ClinicalTrials.gov.